Piermont Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-52,195
| Closed | -$481K | – | 279 |
|
|
2017
Q1 | $481K | Buy |
+52,195
| New | +$481K | 0.11% | 234 |
|
|
2016
Q2 | – | Sell |
-21,895
| Closed | -$221K | – | 315 |
|
|
2016
Q1 | $221K | Buy |
21,895
+835
| +4% | +$8.43K | 0.07% | 227 |
|
|
2015
Q4 | $475K | Sell |
21,060
-1,440
| -6% | -$32.5K | 0.15% | 150 |
|
|
2015
Q3 | $373K | Hold |
22,500
| – | – | 0.12% | 180 |
|
|
2015
Q2 | $506K | Buy |
+22,500
| New | +$506K | 0.15% | 165 |
|